AZTherapies Completes COGNITE Phase 3 Alzheimer’s Clinical Trial; Top-Line Data Readout Expected in First Quarter of 2021
18 nov. 2020 08h35 HE
|
AZTherapies, Inc.
Last Patient/Last Visit completed on November 13th enabling full clinical database lock BOSTON, Nov. 18, 2020 (GLOBE NEWSWIRE) -- AZTherapies, Inc., a biopharmaceutical company in advanced clinical...
AZTherapies Doses First Patient in Phase 2a Study of ALZT-OP1a in Amyotrophic Lateral Sclerosis (ALS)
09 sept. 2020 08h34 HE
|
AZTherapies, Inc.
BOSTON, Sept. 09, 2020 (GLOBE NEWSWIRE) -- AZTherapies, Inc., a biopharmaceutical company in advanced clinical trials to treat neuroinflammatory diseases, today announced the dosing of the first...
AZTherapies Announces the Appointment of Drs. Robert Malenka, Adam Boxer, Vijay Kuchroo and Megan Levings, to Scientific Advisory Board
11 août 2020 08h35 HE
|
AZTherapies, Inc.
BOSTON, Aug. 11, 2020 (GLOBE NEWSWIRE) -- AZTherapies, Inc., a biopharmaceutical company in advanced clinical trials to treat neuroinflammatory diseases, today announced the expansion of its...
AZTherapies Strengthens Board of Directors & Business Advisory Board with New Appointments
22 juil. 2020 08h35 HE
|
AZTherapies, Inc.
Noah Gottdiener of Duff & Phelps and Thierry Porté of J.C. Flowers & Co. join BOD Retired Eli Lilly executive Joseph B. Kelley joins Business Advisory Board BOSTON, July 22, 2020 (GLOBE...
AZTherapies Strengthens Neuroinflammation-Targeted Pipeline Through Acquisition of Smith Therapeutics
24 oct. 2019 08h32 HE
|
AZTherapies, Inc.
Cutting-edge CAR-Treg technology could have broad application across common and rare neurodegenerative diseases Smith Founder and CEO Philip Ashton-Rickardt, Ph.D. joins as SVP of Immunology ...
INmune Bio Awarded a $1 Million Grant for the Development of XPro1595 for the treatment of Alzheimer’s Disease
11 févr. 2019 08h00 HE
|
INmune Bio, Inc.
The Alzheimer’s Association awarded INmune Bio the Part the Cloud to RESCUE grant to target neuroinflammation in Alzheimer’s Disease LA JOLLA, Calif., Feb. 11, 2019 (GLOBE NEWSWIRE) -- INmune...
CreAgri Commitment to Neuroprotection Grows With Sponsorship to Major International Meeting About Prions and Alzheimer
23 mai 2014 06h30 HE
|
CreAgri, Inc.
HAYWARD, Calif., May 23, 2014 (GLOBE NEWSWIRE) -- Furthering its investment the area of neuroinflammation and neuroprotection CreAgri is focusing upon a number of close relationships with selected...